A recent study confirmed that interleukin-13 (IL-13)+ type 2 innate lymphoid cells (ILC2s) in peripheral blood are associated more strongly than Th2 cells with asthma severity and GC resistance in humans [9]. This evidence concerns the gene IL13 and asthma.